Literature DB >> 16734627

Polyomavirus-associated nephropathy: updates on a persisting challenge.

E Ramos, H H Hirsch.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16734627     DOI： 10.1111/j.1399-3062.2006.00164.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN： 1398-2273            Impact factor:   2.228


× No keyword cloud information.
  5 in total

1.  Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation.

Authors:  Steven Gabardi; Sushrut S Waikar; Spencer Martin; Keri Roberts; Jie Chen; Lea Borgi; Hussein Sheashaa; Christine Dyer; Sayeed K Malek; Stefan G Tullius; Nidyanandh Vadivel; Monica Grafals; Reza Abdi; Nader Najafian; Edgar Milford; Anil Chandraker
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

2.  The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Chunqing Luo; Ron Shapiro; Diana Metes; Geetha Chalasani; Parmjeet S Randhawa
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

3.  Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia.

Authors:  Kosuke Masutani; Ron Shapiro; Amit Basu; Henkie Tan; Toshiharu Ninomiya; Parmjeet Randhawa
Journal:  Transplantation       Date:  2012-07-15       Impact factor: 4.939

4.  HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia.

Authors:  Kosuke Masutani; Toshiharu Ninomiya; Parmjeet Randhawa
Journal:  Nephrol Dial Transplant       Date:  2013-09-30       Impact factor: 5.992

5.  Routine immunohistochemistry study for polyomavirus BK nephropathy in transplanted kidney biopsies, is it recommended?

Authors:  Fatemeh Nili; Maliheh Mohammadhoseini; Seyed Mohammadreza Khatami; Golnar Seirafi; Majidreza Haghzare
Journal:  BMC Nephrol       Date:  2021-06-18       Impact factor: 2.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.